Tranquillisation or asleep · patients with psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes tranquillisation or asleep not asleep at 60 minutes compared with BENZODIAZEPINE: b. LORAZEPAM (very low certainty).
1 finding from 1 review
Specific behaviour ‐ threat or injury to self or others within 24 hours ‐ not reported · patients with psychosis‐induced aggression or agitation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global outcome: no overall improvement ‐ at 30 minutes · patients with psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes global outcome: no overall improvement ‐ at 60 minutes compared with BENZODIAZEPINE: b. LORAZEPAM (very low certainty).
1 finding from 1 review
Adverse effects: specific ‐ dystonia · patients with psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes adverse effects: specific ‐ dystonia (only reported if occurred in… compared with BENZODIAZEPINE: b. LORAZEPAM (very low certainty).
1 finding from 1 review
Specific behaviours ‐ agitation: average change score at 2 hours CABS · patients with psychosis‐induced aggression or agitation
1 finding from 1 review
Adverse effects: Specific ‐ hypertonia/rigidity (only reported if occurred in ≥9%) during 24 hours · patients with psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes adverse effects: specific ‐ hypertonia/rigidity (only reported if… compared with BENZODIAZEPINE: b. LORAZEPAM (very low certainty).
1 finding from 1 review
Economic outcome ‐ not reported · patients with psychosis‐induced aggression or agitation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Tranquillisation or asleep ‐ not reported · patients with psychosis‐induced aggression or agitation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Specific behaviour ‐ threat or injury to self or others ‐ not reported · patients with psychosis‐induced aggression or agitation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global outcome Need for rescue drug · patients with psychosis‐induced aggression or agitation
HALOPERIDOL showed no clear difference in global outcome Need for rescue drug compared with BENZODIAZEPINE: c. MIDAZOLAM (low certainty).
1 finding from 1 review
Adverse drug effects · patients with psychosis‐induced aggression or agitation
HALOPERIDOL showed no clear difference in adverse effects ‐ general ‐ one or more drug‐related adverse effect compared with BENZODIAZEPINE: c. MIDAZOLAM (low certainty).
1 finding from 1 review
Economic outcome ‐ not reported · patients with psychosis‐induced aggression or agitation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Tranquillisation or asleep ‐ not reported · patients with psychosis‐induced aggression or agitation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Repeated need for tranquillisation ‐ not reported · patients with psychosis‐induced aggression or agitation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality (N) Mean hospital stay: 2‐7 days
1 finding from 1 review
Morbidity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events other than hypoglycaemic episodes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to resolution of diabetic ketoacidosis (h) Mean hospital stay: 3‐5 days
1 finding from 1 review
Patient satisfaction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay
1 finding from 1 review